Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review
Abstract Background Glioma is still one of the most aggressive and common types of brain and central nervous system cancer, with few effective treatment options. Despite progress in therapy, there is a requirement for new methods to enhance patient outcomes. Doxorubicin (DOX), a type of anthracyclin...
Saved in:
| Main Authors: | Elyar Mahboubi, Mahdieh Mondanizadeh, Amir Almasi-Hashiani, Elham Ghasemi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | European Journal of Medical Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40001-025-02674-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center
by: Ted Kim, et al.
Published: (2025-03-01) -
Transposable Element Is Predictive of Chemotherapy- and Immunotherapy-Related Overall Survival in Glioma
by: Bi Peng, et al.
Published: (2025-05-01) -
Clinical and Survival Insights into Carcinoma Penis: A Retrospective Analysis at a Tertiary Care Facility
by: Santosh Kumar Swain, et al. -
Extended Survival and Prognostic Factors in Endometrial Cancer: A Multivariate Cox Regression Analysis
by: Irene Valencia Téllez, et al.
Published: (2024-12-01) -
Development and Validation of Nomograms to Predict the Overall Survival and Progression-Free Survival in Patients with Advanced Unresectable Intrahepatic Cholangiocarcinoma
by: Xian F, et al.
Published: (2024-12-01)